Sarah Clifford1, Nick Barber, Rob Horne. 1. Department of Practice and Policy, The School of Pharmacy, University of London, London, United Kingdom. sarah.clifford@pharmacy.ac.uk <sarah.clifford@pharmacy.ac.uk>
Abstract
OBJECTIVE: The objective of this study was to explore beliefs about medicines, using the Necessity-Concerns Framework, of patients who report adherence, unintentional nonadherence, and intentional nonadherence. METHOD: This study performed a cross-sectional survey of patients starting a new medication for a chronic condition. Self-reported adherence was assessed via telephone interview. The Necessity-Concerns Framework was operationalized using the Beliefs About Medicines Questionnaire, which assesses beliefs about the necessity of and concerns with taking medications. RESULTS: Intentional nonadherers, compared to adherers, had lower perceptions of the necessity of their new medication and higher levels of concerns about taking it. Conversely, unintentional nonadherers were not significantly different from adherers. Intentional nonadherers were more likely to rate their concerns as high relative to their need for treatment than both adherers and unintentional nonadherers. CONCLUSION: When patients start a new medication for a chronic condition, intentional nonadherers hold beliefs significantly different from those of adherers and unintentional nonadherers. These findings have implications for practice in helping clinicians to reduce this type of nonadherence.
OBJECTIVE: The objective of this study was to explore beliefs about medicines, using the Necessity-Concerns Framework, of patients who report adherence, unintentional nonadherence, and intentional nonadherence. METHOD: This study performed a cross-sectional survey of patients starting a new medication for a chronic condition. Self-reported adherence was assessed via telephone interview. The Necessity-Concerns Framework was operationalized using the Beliefs About Medicines Questionnaire, which assesses beliefs about the necessity of and concerns with taking medications. RESULTS: Intentional nonadherers, compared to adherers, had lower perceptions of the necessity of their new medication and higher levels of concerns about taking it. Conversely, unintentional nonadherers were not significantly different from adherers. Intentional nonadherers were more likely to rate their concerns as high relative to their need for treatment than both adherers and unintentional nonadherers. CONCLUSION: When patients start a new medication for a chronic condition, intentional nonadherers hold beliefs significantly different from those of adherers and unintentional nonadherers. These findings have implications for practice in helping clinicians to reduce this type of nonadherence.
Authors: Gabriel S Tajeu; Shia T Kent; Ian M Kronish; Lei Huang; Marie Krousel-Wood; Adam P Bress; Daichi Shimbo; Paul Muntner Journal: Hypertension Date: 2016-07-18 Impact factor: 10.190
Authors: Rebecca Dickinson; Peter Knapp; Allan O House; Vandana Dimri; Arnold Zermansky; Duncan Petty; John Holmes; David K Raynor Journal: Br J Gen Pract Date: 2010-04 Impact factor: 5.386
Authors: Talitha I Verhoef; W Ken Redekop; Marcel L Bouvy; Brenda Dorenbos; Zamiera Karwar; Rianne M F van Schie; Anthonius de Boer; Anke-Hilse Maitland-van der Zee Journal: Br J Clin Pharmacol Date: 2014-08 Impact factor: 4.335
Authors: Alyce S Adams; Connie Uratsu; Wendy Dyer; David Magid; Patrick O'Connor; Arne Beck; Melissa Butler; P Michael Ho; Julie A Schmittdiel Journal: JAMA Intern Med Date: 2013-01-14 Impact factor: 21.873